Pilot Study of BCAA on Sleep
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-89
SponsorPortland VA Medical Center
About this trial
Individuals will be recruited from the VA Portland Health Care System and the community affiliated with Oregon Health \& Science University. Traumatic brain injury status will be assessed as a contributing factor. Subjects will be randomized to one of 3 groups (BCAA or one of 2 placebo conditions) and instructed to consume study product twice daily for 21 days. Self-report questionnaires, wrist actigraphy, pressure pain testing, and cognitive function will be assessed pre and post the experimental period.
Eligibility criteria
Qualifiers
Veteran
English Speaking
Accessible via phone
Sleep problems
Disqualifiers
Decisional impairment
Nickel allergy
Maple syrup urine disease or family history of disease
Allergy to sucralose
Trial design
Treatments tested in this trial
- Branched Chain Amino Acids
- Rice Protein
- Microcrystalline Cellulose
Treatment groups
300 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov